CDC to assess prescribing rates, board to seek comments

The Centers for Disease Control & Prevention (CDC) says that it will conduct a project to “address some key questions around opioid prescribing to help curtail the current opioid overdose epidemic in our nation.”

CDC will use health insurance claims data to “calculate how much the current prescribing rates for acute and chronic pain would need to change across the U.S. population to be consistent with best practices.”

It will “follow a rigorous and transparent scientific process in conducting this work and will ask CDC’s National Center for Injury Prevention and Control’s (NCIPC) Board of Scientific Counselors (BSC), a federal advisory committee, to establish a workgroup (to provide expert input regarding the process and findings).”

CDC plans to “share these findings in the Federal Register for public comment. Findings will be submitted for publication in a scientific journal, from which materials will be developed to help translate and disseminate findings to clinicians and the public. Translational materials will be aimed at improving the safety and effectiveness of pain treatment, while reducing the risks associated with opioid therapy.”

BSC will address this issue during a public hearing that will take place from 8:30 a.m. to 5:15 p.m. on Tuesday, June 19 and 8:30 a.m. to 12:15 p.m. on Wednesday, June 20.

BSC says the “meeting is open to the public and individuals can participate and make a public comment in-person or by telephone…individuals making public comments during the meeting will have a two-minute speaking limit…”

Click for hearing details

Click to register for hearing